Aprindine: a review.
D000284:Administration, Oral; D000380:Agranulocytosis / Q000139:chemically induced; D000818:Animals; D001073:Aprindine / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007192:Indenes / Q000627:therapeutic use*; D007275:Injections, Intravenous
D007192:Indenes; D001073:Aprindine